to all aminoglycosides, to fluoroquinolones, nitrofurantoin, chloramphenicol, and 19 trimethoprim-sulfamethoxazole. It was susceptible only to tigecycline and colistin (MICs at 20 0.5 µg/ml for both). E. coli SAL2 was resistant to all ß-lactams, with MICs of carbapenems 21 being all ≥32 µg/ml, and also to fluoroquinolones, tetracycline, gentamicin, tobramycin, and 22 sulfonamides, being only susceptible to tigecycline and colistin (same MICs as above). 23
According to phenotypic test results (synergy between aztreonam and clavulanate), both 24 isolates produced extended-spectrum ß-lactamases (ESBLs). Metallo-ß-lactamase (MBL) 25 detection performed by using the Etest combining imipenem and EDTA (AB bioMérieux, 26 Solna, Sweden) gave a positive result for K. pneumoniae SAL1. 27 PCR, sequencing and plasmid analysis revealed that K. pneumoniae SAL1 harbored the 28 bla NDM-1 carbapenemase gene (10), in addition to the ESBL gene bla CTX-M-15 , both being 29 located on different plasmids (80 and 160 kb in size, respectively). On the other hand, E. coli 30 SAL2 harbored the bla OXA-48 carbapenemase gene, in addition to bla CTX-M-15 , both being also 31 located on different plasmids (62 and 100 kb in-size, respectively). Screening for additional ß-32 lactamase genes (10) and for 16S RNA methylase genes as reported (1) showed that K. Since occurrence of NDM-1-producing K. pneumoniae is now increasingly reported, 44 tracing the strain backgrounds is interesting and therefore multilocus sequence typing was 45 performed as described (4) and results analyzed by eBURST (http://pubmlst.org). It showed 46 that isolate SAL1 belonged to the ST38 sequence type that corresponds to an ST distantly 47 related to those of other NDM-1-positive K. pneumoniae isolate identified so far, including 48 that one identified from Iraq (11). 49
This study constitutes the very first report of an NDM-1-positive isolate in Turkey, 50 further underlining the wide spread of that resistance trait. Since NDM-1 had been already 51 identified in Iraq, it is likely here that the patient was already colonized when admitted at the 52 on October 2, 2017 by guest http://aac.asm.org/ Downloaded from Turkish hospital. This would further indicate that the Middle East and Iraq in particular may 53 be reservoirs of NDM-producing isolates, in addition to the Indian subcontinent and the 54 Balkans (5, 6). On the other hand, the co-infection with an OXA-48-producing E. coli might 55 be nosocomial, since Turkey is known to be an endemic area for OXA-48-producing 56
Enterobacteriaceae. However, since no other OXA-48-producing E. coli have been identified 57 in the same hospital during the same period of time, the hypothesis of an importation together 58 with the NDM-1-producing isolate remains plausible. 59
